Integrated analysis of intestinal microbiota and metabolomic reveals that decapod iridescent virus 1 (DIV1) infection induces secondary bacterial infection and metabolic reprogramming in Marsupenaeus japonicus

Abstract

In recent years, with global warming and increasing marine pollution, some novel marine viruses have become widespread in the aquaculture industry, causing huge losses to the aquaculture industry. Decapod iridescent virus 1 (DIV1) is one of the newly discovered marine viruses that has been reported to be detected in a variety of farmed crustacean and wild populations. Previous studies have found that DIV1 can induce the Warburg effect. To further explore the effect of DIV1-induced metabolic reprogramming on Marsupenaeus japonicus intestinal metabolome and microbiota and the consequence on immune response, histological analysis, enzyme activity analysis and the integrated analysis of intestinal microbiome and metabolomics were performed in this study. The results showed that obvious injury in the intestinal mucosa was observed after DIV1 infection. The oxidative and antioxidant capacity of the shrimp intestine was unbalanced, the activity of lysozyme was decreased, and the activities of digestive enzymes were disordered, causing secondary bacterial infection. In addition, the increased abundance of harmful bacteria, such as Photobacterium and Vibrio, synergized with DIV1 to promote the Warburg effect and induce metabolic reprogramming, thereby providing material and energy for DIV1 replication. This study is the first to report the changes of intestinal microbiota and metabolites of M. japonicus under DIV1 infection, demonstrating that DIV1 can induce secondary bacterial infection and metabolic reprogramming, and several highly related bacteria and metabolites were screened as biomarkers. These biomarkers can be leveraged for diagnosis of pathogenic infections or incorporated as exogenous metabolites to enhance immune response.